Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

CUSIP: N69605108

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Ordinary Shares, Euro 0.12 par value per share
Shares outstanding
65,632,680
Total 13F shares
57,844,608
Share change
+9,379,765
Total reported value
$1,443,142,875
Price per share
$24.95
Number of holders
83
Value change
+$236,461,176
Number of buys
66
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP N69605108?
CUSIP N69605108 identifies PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q3 2025

As of 30 Sep 2025, Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,844,608 shares. The largest 10 holders included GENERAL ATLANTIC, L.P., FMR LLC, Foresite Capital Management IV, LLC, venBio Partners LLC, VIKING GLOBAL INVESTORS LP, EQT Fund Management S.a r.l., Bain Capital Life Sciences Investors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Commodore Capital LP, and Paradigm Biocapital Advisors LP. This page lists 83 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.